S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
JP Morgan analyst: Oil to hit $380 per barrel (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
Did You See These Trend Reversals? (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
What’s At Stake In April is Shocking (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
JP Morgan analyst: Oil to hit $380 per barrel (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
Did You See These Trend Reversals? (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
What’s At Stake In April is Shocking (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
JP Morgan analyst: Oil to hit $380 per barrel (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
Did You See These Trend Reversals? (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
What’s At Stake In April is Shocking (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
JP Morgan analyst: Oil to hit $380 per barrel (Ad)
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
Did You See These Trend Reversals? (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
What’s At Stake In April is Shocking (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

$21.26
+0.16 (+0.76%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$21.17
$21.50
50-Day Range
$17.78
$21.26
52-Week Range
$12.78
$34.65
Volume
565,584 shs
Average Volume
1.03 million shs
Market Capitalization
$12.48 billion
P/E Ratio
17.72
Dividend Yield
2.30%
Price Target
$28.20

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Hold
1.60 Rating Score
Upside/​Downside
32.6% Upside
$28.20 Price Target
Short Interest
Healthy
0.57% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.25mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
30.70%
From $1.14 to $1.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

105th out of 996 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 9 stocks


FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Fresenius Confirms Review Of Deconsolidation Of Fresenius Medical Care
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
3 Stocks With Dividends of 3% or More to Buy on the Dip
Fresenius Medical's (FMS) Q3 Earnings and Revenues Top
10 Best European Dividend Stocks to Buy Now
FMS Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS)
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings
2/21/2023
Today
4/02/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,235
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$28.20
High Stock Price Forecast
$51.80
Low Stock Price Forecast
$11.70
Forecasted Upside/Downside
+32.6%
Consensus Rating
Hold
Rating Score (0-4)
1.60
Research Coverage
10 Analysts

Profitability

Net Income
$709.50 million
Pretax Margin
6.29%

Debt

Sales & Book Value

Annual Sales
$20.44 billion
Cash Flow
$5.09 per share
Book Value
$27.74 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.48 billion
Optionable
Optionable
Beta
1.00

Social Links


Key Executives

  • Helen Giza
    Chief Executive & Financial Officer
  • Franklin W. Maddux
    Global Chief Medical Officer
  • Dominik Heger
    Senior VP, Head-IR & Corporate Communications
  • William Valle
    Chief Executive Officer-North America
  • Katarzyna Mazur-Hofsaess
    CEO-Europe, Middle East & Africa













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 4 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

10 Wall Street research analysts have issued 1 year target prices for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $11.70 to $51.80. On average, they predict the company's stock price to reach $28.20 in the next twelve months. This suggests a possible upside of 32.6% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 at the start of the year. Since then, FMS shares have increased by 30.1% and is now trading at $21.26.
View the best growth stocks for 2023 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 3,370,000 shares, an increase of 74.6% from the February 28th total of 1,930,000 shares. Based on an average trading volume of 932,100 shares, the short-interest ratio is currently 3.6 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) posted its earnings results on Tuesday, February, 21st. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.22. The business had revenue of $5.10 billion for the quarter, compared to analysts' expectations of $4.85 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 5.80% and a net margin of 3.46%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Investors of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS
.

What ETFs hold Fresenius Medical Care AG & Co. KGaA's stock?
Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.38%. The dividend payout ratio is 40.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 32.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $21.26.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $12.48 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.20 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 1,235 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 4/2/2023 by MarketBeat.com Staff